0000899243-18-025192.txt : 20180925
0000899243-18-025192.hdr.sgml : 20180925
20180925180556
ACCESSION NUMBER: 0000899243-18-025192
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180921
FILED AS OF DATE: 20180925
DATE AS OF CHANGE: 20180925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Milligan Peter J
CENTRAL INDEX KEY: 0001531049
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35405
FILM NUMBER: 181086512
MAIL ADDRESS:
STREET 1: 1650 TYSONS BOULEVARD
STREET 2: SUITE 1700
CITY: MCLEAN
STATE: VA
ZIP: 22102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MELINTA THERAPEUTICS, INC. /NEW/
CENTRAL INDEX KEY: 0001461993
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454440364
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 GEORGE STREET
STREET 2: SUITE 301
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 312 767 0291
MAIL ADDRESS:
STREET 1: 300 GEORGE STREET
STREET 2: SUITE 301
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
FORMER COMPANY:
FORMER CONFORMED NAME: CEMPRA, INC.
DATE OF NAME CHANGE: 20120203
FORMER COMPANY:
FORMER CONFORMED NAME: Cempra Holdings, LLC
DATE OF NAME CHANGE: 20090414
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-21
0
0001461993
MELINTA THERAPEUTICS, INC. /NEW/
MLNT
0001531049
Milligan Peter J
C/O MELINTA THERAPEUTICS, INC.
300 GEORGE STREET, SUITE 301
NEW HAVEN
CT
06511
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
4.50
2018-09-21
4
A
0
370000
0.00
A
2028-09-21
Common Stock
370000
370000
D
One-quarter of the options will vest and become exercisable on September 17, 2019 and the remainder will vest and become exercisable in substantially equal monthly installments during the three year period commencing on September 17, 2019, subject to Mr. Milligan's continued service with the Company through the applicable vesting date.
/s/ Peter Milligan
2018-09-24